lobbying_activities: 2466419

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2466419	7bf57d7a-93d8-494c-b8b5-8ec1a9269ddb	Q2	ERIN SMITH/ SMITH CAPITOL STRATEGIES	401105486	TWIST BIOSCIENCE	2020	second_quarter	SCI	Supporting the bioeconomy, COVID-19 synthetic biology policy.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE			0	0	2020-07-15T13:37:21.620000-04:00